# BAY86-5046 (Betaseron), Non Interventional Studies

> **NCT02121444** · — · COMPLETED · sponsor: **Bayer** · enrollment: 151 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Interferon beta-1b (Betaferon, BAY 86-5046)
- **DEVICE:** BETACONNECT auto-injector.

## Key facts

- **NCT ID:** NCT02121444
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-23
- **Primary completion:** 2016-03-09
- **Final completion:** 2016-06-01
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2017-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02121444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02121444, "BAY86-5046 (Betaseron), Non Interventional Studies". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02121444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*